Last update 01 Nov 2024
APL-4098
Last update 01 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism kinase inhibitor |
Therapeutic Areas |
Inactive Indication- |
Originator Organization  Apollo Therapeutics LLPStartup |
Active Organization Apollo Therapeutics LLPStartup |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with APL-4098A Phase 1/2 Study to Assess the Safety and Antitumor Activity of APL-4098 Alone and/or in Combination With Azacitidine in Adults With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome/AML (MDS/AML) or Myelodysplastic Syndrome With Excess Blasts (MDS-EB)
100 Clinical Results associated with APL-4098
Login to view more data
100 Translational Medicine associated with APL-4098
Login to view more data
100 Patents (Medical) associated with APL-4098
Login to view more data
100 Deals associated with APL-4098
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Myeloid Leukemia with Myelodysplasia-Related Changes | Phase 2 | AU | Apollo Therapeutics LLPStartup | 04 Jun 2024 |
| High Risk Myelodysplastic Syndrome | Phase 2 | AU | Apollo Therapeutics LLPStartup | 04 Jun 2024 |
| Relapsing acute myeloid leukemia | Phase 2 | AU | Apollo Therapeutics LLPStartup | 04 Jun 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free